Santhera Pharmaceuticals Holding Ltd has successfully placed CHF60m 5% convertible bonds due 2022. The convertible bonds will mature on 17 February 2022 at 100% of their principal amount unless previously redeemed, converted or repurchased and cancelled.
The terms of the convertible bonds provide for a reset of the conversion price if the average share price during a period immediately prior to the first anniversary of the issue date falls below a reference share price. Bank am Bellevue AG and Kepler Cheuvreux SA acted as joint bookrunners in this transaction.
Bär & Karrer acted as legal adviser to the joint bookrunners. The team included Thomas U Reutter, Daniel Raun, Annette Weber and Michael Schneitter (all Capital Markets) as well as Susanne Schreiber and Michael Abegg (both Tax).
#1 Lawyers Search Engine